Sanofi (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/s0022-3565(25)22957-3 SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
https://doi.org/10.1016/s0040-4039(00)60102-8 Metallation of 2-phenylindolizine
https://doi.org/10.1016/0223-5234(94)90191-0 1-[[4-(Aminoalkoxy)phenyl]sulfonyl]indolizines: a novel class of calcium entry blockers. Relationships between chemical structure, stereoelectronic properties and anticalcic activity
https://doi.org/10.1039/c7nr07393c Carbon nanotubes as nanovectors for intracellular delivery of laronidase in Mucopolysaccharidosis type I
https://doi.org/10.1200/jco.2014.32.3_suppl.545 Ziv-aflibercept in combination with FOLFIRI for second-line treatment of patients with metastatic colorectal cancer (mCRC): Interim safety data from the global aflibercept safety and quality-of-life program (ASQoP and AFEQT studies) in patients ≥65.
https://doi.org/10.1212/wnl.96.15_supplement.4195 Efficacy and Safety Results of the Avalglucosidase alfa Phase 3 COMET Trial in Late-Onset Pompe Disease Patients (4195)
https://doi.org/10.1097/01.hs9.0000560864.06450.a4 PF645 EXPOSURE‐RESPONSE ANALYSIS & DISEASE MODELING FOR SELECTION OF OPTIMAL DOSING REGIMEN OF ISATUXIMAB AS SINGLE AGENT IN PATIENTS WITH MULTIPLE MYELOMA
https://doi.org/10.1093/annonc/mdx262.011 Impact of prior bevacizumab treatment on VEGFA and PlGF levels and patient outcomes: A retrospective analysis of baseline plasma samples from the VELOUR trial
https://doi.org/10.1080/00015385.2020.1820683 Feasibility and cost of FH cascade screening in Belgium (BEL-CASCADE) including a novel rapid rule-out strategy
https://doi.org/10.1016/j.jaci.2020.12.149 Children With Atopic Dermatitis (AD) Have a High Burden of Atopic Comorbidities: Results From a Large Worldwide Survey
https://doi.org/10.4155/bio-2021-0137 Cloud Solutions for GxP Laboratories: Considerations for Data Storage
https://doi.org/10.1002/mame.202400029 Transdermal Administration of Nanobody Molecules using Hydrogel‐Forming Microarray Patch Technology: A Unique Delivery Approach
https://doi.org/10.1183/13993003.congress-2023.oa4296 Late Breaking Abstract - Early improvement in asthma small airway dysfunction after one dose of SAR443765, a novel bispecific anti-thymic stromal lymphopoietin/anti-IL-13 nanobody molecule
https://doi.org/10.1200/jco.2014.32.3_suppl.556 Ziv-aflibercept (Z) in combination with FOLFIRI for second-line treatment of patients (pts) with metastatic colorectal cancer (mCRC): Interim safety data from the global aflibercept safety and quality-of-life program in pts pretreated with bevacizumab (B).
https://doi.org/10.1016/0006-2952(83)90004-7 Cardiac β-adrenoceptor modulation by amiodarone
https://doi.org/10.1016/0006-291x(85)91415-9 Effect of amiodarone on membrane fluidity and Na+K+ ATPase activity in rat-brain synaptic membranes
https://doi.org/10.1002/jps.2600740720 Amiodarone Partitioning with Phospholipid Bilayers and Erythrocyte Membranes
https://doi.org/10.1111/j.1439-0450.1993.tb00156.x Detection of Galactomannan and the 18 kDa Antigen from Aspergillus fumigatus in Serum and Urine from Cattle with Systemic Aspergillosis
https://doi.org/10.1016/s0022-3565(25)22918-4 SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
https://doi.org/10.1016/0014-2999(87)90012-4 Prevention by amiodarone of phospholipid depletion in isoproterenol-induced ischemia in rats
https://doi.org/10.1016/b978-0-08-052349-1.00206-7 Oxidation of Carbon–Halogen Bonds
Prevention of calcium overload and down-regulation of calcium channels in rat heart by SR 33557, a novel calcium entry blocker.
https://doi.org/10.1016/0922-4106(93)90030-d In vitro characterization of a novel Ca2+ entry blocker: SR 33805
https://doi.org/10.1182/blood-2019-123720 Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity
https://doi.org/10.22541/au.158888178.87297637 Pediatric Cancer Research: Surviving COVID-19
https://doi.org/10.1212/wnl.94.15_supplement.695 NEO1 and NEO-EXT Studies: Long-Term Safety and Exploratory Efficacy of Repeat Avalglucosidase Alfa Dosing for 5.5 Years in Late-Onset Pompe Disease Patients (695)
https://doi.org/10.1200/jco.2014.32.15_suppl.3639 The consistency of effect of ziv-aflibercept (Z) in the bevacizumab (B) pre-treated subgroup of patients (pts) in the velour trial stratified by first-line progression ≥ 9 months (mos) versus < 9 mos.
https://doi.org/10.1200/jco.2015.33.3_suppl.528 Ziv-aflibercept (Z) in combination with FOLFIRI for second-line treatment of patients (pts) with metastatic colorectal cancer (mCRC): Interim safety data from the global Aflibercept Safety and Quality-of-Life Program in pts pretreated with bevacizumab (B).
https://doi.org/10.5731/pdajpst.2021.012726 Challenges Encountered in the Implementation of Bio-Fluorescent Particle Counting Systems as a Routine Microbial Monitoring Tool
https://doi.org/10.1182/blood-2019-123126 Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen
https://doi.org/10.1016/j.jaad.2021.06.588 27430 Worldwide survey shows that atopic dermatitis is associated with a high disease burden in children
https://doi.org/10.1007/s10928-024-09958-z Translational pharmacokinetic and pharmacodynamic modelling of the anti-ADAMTS-5 NANOBODY® (M6495) using the neo-epitope ARGS as a biomarker
https://doi.org/10.1186/s13023-025-03692-6 TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care project
https://doi.org/10.1179/acb.2004.050 COST CONSEQUENCE ANALYSIS OF FONDAPARINUX VERSUS ENOXAPARIN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER MAJOR ORTHOPAEDIC SURGERY IN BELGIUM
Clinical practice and costs of treating catheter-related infections with teicoplanin or vancomycin.
https://doi.org/10.1002/jlcr.2580221102 Synthese de L'Acide (Propyl‐1‐13C)‐2 Pentanoique‐3‐13C (acide valproïque)
https://doi.org/10.4155/bio-2020-0150 European Immunogenicity Platform 11th Open Scientific Symposium on Immunogenicity of Biopharmaceuticals
https://doi.org/10.1182/blood-2021-148839 Long-Term Safety and Efficacy of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura (aTTP): The Post-HERCULES Study
https://doi.org/10.1016/j.jval.2018.09.2766 PSY192 - PATIENT HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH REMISSION OF ATTP, A REGRESSION ANALYSIS USING NON-RANDOMISED OBSERVATIONAL DATA FROM THE OKLAHOMA TTP REGISTRY
https://doi.org/10.1158/1538-7445.am2022-2909 Abstract 2909: CD123-CODV-TCE bispecific T-cell engager for acute myeloid leukemia (AML): Activity on primary AML and safety in non-human primates
https://doi.org/10.4155/bio-2022-0232 Feedback from the 8th European Bioanalysis Forum Young Scientist Symposium
https://doi.org/10.1097/01.hs9.0000972352.86009.7f P1366: SAR442257, A CD38/CD28/CD3 TRISPECIFIC ANTIBODY, POTENTIATES CAR T-CELL ACTIVITY AGAINST LARGE B-CELL LYMPHOMA
https://doi.org/10.1183/13993003.congress-2023.pa3948 Machine learned decision tree for diagnosis of ASMD among patients with unexplained ILD
https://doi.org/10.1136/jitc-2023-sitc2023.0272 272 PD-L1 CAR engineered K-NK cells to target PD-L1+ or PD-L1- tumors
https://doi.org/10.4155/bio-2024-0054 Feedback from the Science Café roundtables at the ninth European Bioanalysis Forum Young Scientist Symposium: optimizing the work–life balance in a bioanalytical laboratory
https://doi.org/10.1093/bjd/ljae266.072 698 - Impact of amlitelimab (an anti-OX40 ligand antibody) on clinical outcome assessments for atopic dermatitis: results from the 52-week STREAM-AD phase 2b study in adults with moderate-to-severe atopic dermatitis
https://doi.org/10.1183/13993003.congress-2024.pa1222 Elevated fractional exhaled nitric oxide is prevalent in those with mild-to-moderate asthma with self-reported asthma control
https://doi.org/10.1164/ajrccm.2025.211.abstracts.a2914 Development and Validation of Machine-learned Algorithms for Diagnosing ASMD Among Patients With Unexplained ILD
https://doi.org/10.1007/bf00498853 Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardium
https://doi.org/10.1111/j.1699-0463.1993.tb00140.x Enzyme immunohistochemistry with mono- and polyclonal antibodies in the pathological diagnosis of systemic bovine mycoses
https://doi.org/10.2165/00003495-198500293-00002 Amiodarone*
https://doi.org/10.1016/0006-2952(89)90328-6 Differential effects of amiodarone and propranolol on lipid dynamics and enzymatic activities in cardiac sarcolemmal membranes
https://doi.org/10.1016/0922-4106(93)90071-g Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436
https://doi.org/10.1007/bf00736049 Amiodarone is a potent calmodulin antagonist
https://doi.org/10.1016/s0022-2828(87)80366-8 Protective effects of amiodarone pretreatment on mitochondrial function and high energy phosphates in ischaemic rat heart
https://doi.org/10.1016/0140-6736(92)90261-z Aspergillus antigen latex test for diagnosis of invasive aspergillosis
https://doi.org/10.1016/0378-1119(92)90562-4 Immunodiagnosis of nocardiosis
https://doi.org/10.1111/j.1527-3466.1991.tb00407.x SR 33557: A Slow Calcium Channel Antagonist with a Novel Site of Action
https://doi.org/10.1007/bf01871015 Modulation byn-alkanols of rat cardiac adenylate cyclase activity
https://doi.org/10.1097/00005344-199003000-00006 Amiodarone Pretreatment Effects on Ischemic Isovolumic Rat Hearts
https://doi.org/10.1080/02681219380000381 Effect of tissue invasion and treatment with itraconazole or amphotericin B on galactomannan levels in plasma of guinea-pigs with experimental invasive aspergillosis
https://doi.org/10.1016/s0008-6363(95)00186-7 Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker
https://doi.org/10.2307/3504099 Osbornictis piscivora
https://doi.org/10.1016/0014-2999(94)90397-2 31P nuclear magnetic resonance study of the effects of the calcium ion channel antagonist fantofarone on the rat heart
https://doi.org/10.1002/chin.199410181 ChemInform Abstract: Novel Heterocyclic Analogues of the New Potent Class of Calcium Entry Blockers: 1‐((4‐(Aminoalkoxy)phenyl)sulfonyl)indolizines.
https://doi.org/10.2307/3504101 Crossarchus ansorgei
https://doi.org/10.1159/000139161 Fantofarone (SR 33557): Effects on Myocardial Oxygen Consumption and Coronary Blood Flow
https://doi.org/10.1016/j.jbspin.2022.105425 Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels
https://doi.org/10.1016/0014-2999(92)90755-s Fantofarone (SR 33557): effect on post-ischaemic functional recovery in perfused rat hearts
https://doi.org/10.1111/j.1474-8673.1992.tb00337.x Effects of the divalent cations nickel and cadmium on contractions of rat aorta to endothelin‐1
https://doi.org/10.1093/annonc/mdu165.282 Aflibercept/Folfiri vs Placebo/Folfiri in Metastatic Colorectal Cancer: A Post-Hoc Analysis of Median Overall Survival in Velour from the Retrospectively Assessed Time of Starting First-Line Treatment
https://doi.org/10.1016/s1957-2557(15)30253-4 Équilibre glycémique et satisfaction de patients diabétiques de type 2 insuffisamment contrôlés au Maroc : résultats après 6 mois de traitement par insuline glargine
https://doi.org/10.1016/j.jaad.2020.06.162 14148 Pharmacokinetics, safety, and efficacy of dupilumab in children aged ≥2 to <6 years with severe uncontrolled atopic dermatitis (LIBERTY AD PRE-SCHOOL)
https://doi.org/10.1016/j.jaad.2020.06.203 15115 The patient-reported disease burden in pediatric patients with atopic dermatitis: A cross-sectional study in the United States, Canada, Europe, and Japan
https://doi.org/10.1200/jco.2015.33.15_suppl.e14536 Potential predictive and prognostic biomarkers identified in baseline plasma samples from the VELOUR trial.
https://doi.org/10.1002/hon.3164_188 SAR442257, a CD38/CD28/CD3 trispecific antibody, potentiates CAR T‐cell activity against large B‐cell lymphoma
https://doi.org/10.1093/annonc/mdt202.29 Time Course of Adverse Events in the Velour Trial
https://doi.org/10.1093/annonc/mdu333.32 Quality of Life (Qol) on the Aflibercept/Folfiri Regimen: 4Th Interim Analysis of the Global Aflibercept Safety and Health-Related Qol Program
https://doi.org/10.1200/jco.2014.32.15_suppl.e14560 Quality of life maintained on the ziv-aflibercept/FOLFIRI regimen: Third interim analysis of the global aflibercept safety and HR-QOL program.
https://doi.org/10.1016/j.jval.2018.09.2587 PSY10 - PATIENT CHARACTERISTICS AND IN-HOSPITAL MANAGEMENT OF EPISODES OF ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA: A FRENCH REAL-LIFE POPULATION BASED STUDY
https://doi.org/10.1097/01.hs9.0000564208.56135.66 PS1487 EFFECT OF PLASMA EXCHANGE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CAPLACIZUMAB
https://doi.org/10.1182/blood-2019-123124 Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies
https://doi.org/10.1016/j.htct.2020.09.111 Safety of caplacizumab in patients without documented severe adamts13 deficiency during the hercules study
https://doi.org/10.1016/j.htct.2020.09.112 Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura
https://doi.org/10.1158/1538-7445.am2021-1887 Abstract 1887: Anti-CD38/CD28xCD3 trispecific T cell engager induces proliferation of primary T cells and mediates potent killing of primary malignant plasma cells isolated from Multiple Myeloma bone marrow aspirates
https://doi.org/10.1016/j.htct.2021.10.1047 INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
https://doi.org/10.4155/bio-2021-0187 Feedback From the Science Café At the 7Th European Bioanalysis Forum Young Scientist Symposium
https://doi.org/10.1200/jco.2015.33.3_suppl.588 Ziv-aflibercept (Z) in combination with FOLFIRI for second-line treatment of patients with metastatic colorectal cancer (mCRC): Interim safety data from the global Aflibercept Safety and Quality-of-Life Program (ASQoP and AFEQT) in patients age 65 or older.
https://doi.org/10.1002/mrc.1260250310 1H and 13C NMR investigation of conformational isomerism in amiodarone and derivatives
https://doi.org/10.1093/annonc/mdv233.218 P-221 Acquired 5-FU resistance in CRC models is accompanied by upregulation of VEGF-VEGFR1 signaling, increased migration and invasion that can be attenuated by aflibercept
https://doi.org/10.1016/j.jval.2016.09.1525 Hospitalization Cost and Length of Stay Associated with HPV-Related Diseases
https://doi.org/10.1097/01.hs9.0000567472.70005.67 PB2249 CAPLACIZUMAB MODEL-BASED DOSING RECOMMENDATIONS IN PEDIATRIC PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
https://doi.org/10.1136/annrheumdis-2021-eular.2694 AB0266 METHOTREXATE AND CARDIOVASCULAR RISK IN RHEUMATIC DISEASES:A COMPREHENSIVE REVIEW
https://doi.org/10.1007/bf00165122 SR 33557, a novel calcium-antagonist: interaction with [3H]-(�)-nitrendipine and [3H]-(?)-desmethoxy-verapamil binding sites in cerebral membranes
https://doi.org/10.1016/0005-2736(85)90440-7 A semi-empirical conformational analysis of the interaction of n-alkanols with dipalmitoylphosphatidylcholine
https://doi.org/10.1016/s0026-895x(25)10886-9 Characterization of the slow calcium channel binding sites for [3H]SR 33557 in rat heart sarcolemmal membranes.
https://doi.org/10.1111/j.2042-7158.1986.tb03081.x Properties of amiodarone monolayer spread at the air–water interface
https://doi.org/10.1016/0006-2952(87)90665-4 Ionization state of amiodarone mediates its mode of interaction with lipid bilayers
https://doi.org/10.1157/13094258 Vacuna frente al virus del papiloma humano: un nuevo reto para el pediatra
https://doi.org/10.1002/pol.1972.150100719 Synthesis of soluble, branched polyphenyls